PARADEEP157.00

Paradeep Phosphates Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersCOROMANDELCHAMBLFERTFACTPCBLOALIGPLINDOBORAXSPLPETROMcap ₹16,299 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations3,683.02,595.02,242.72,377.43,843.84,104.93,494.03,754.16,872.25,748.74,702.06,124.3
Other Income11.08.630.019.214.935.242.127.341.731.039.821.6
Total Income3,694.02,603.72,272.82,396.63,858.84,140.13,536.23,781.46,913.95,779.74,741.86,145.8
Expenses
+ Cost of Materials Consumed2,017.71,611.01,537.61,716.22,233.62,234.32,476.32,150.53,236.64,201.13,324.63,555.4
+ Purchases of Stock-in-Trade154.8207.715.5396.4640.9477.0141.01,525.01,980.1125.7320.01,857.3
+ Changes in Inventories734.052.396.6-390.6-49.0462.6-105.6-982.844.582.2-261.5-941.9
+ Employee Benefit Expense57.855.957.958.061.560.768.959.981.986.388.287.2
+ Finance Costs95.982.595.390.981.986.4103.186.8140.3127.0156.2131.7
+ Depreciation & Amortisation50.755.257.861.262.664.863.164.189.6101.8125.8105.7
+ Other Expenses462.7385.7387.1450.4531.5534.0566.3535.5872.4780.9788.3846.0
Total Expenses3,573.62,450.22,247.72,382.53,563.03,919.93,313.23,439.16,445.45,505.04,541.55,641.4
EBITDA256.0282.5148.1147.1425.4336.3347.1465.9656.6472.5442.4720.2
EBIT205.3227.390.385.8362.8271.5283.9401.8567.1370.7316.6614.6
Profit
PBT before Exceptional Items120.4153.525.014.2295.8220.2223.0342.3468.5274.7200.3504.4
+ Exceptional Items0.00.00.00.00.00.00.00.00.0-41.31.921.8
Pretax Income120.4153.525.014.2295.8220.2223.0342.3468.5233.4202.2526.2
+ Current Tax0.04.8-7.60.058.549.764.181.1118.947.637.0111.7
+ Deferred Tax30.939.812.47.89.811.8-1.24.97.73.79.621.9
Tax Expense30.944.64.77.868.361.562.986.0126.651.346.6133.6
+ Share of Associates & JVs0.00.01.2-1.00.20.10.0-0.50.00.00.0-0.1
Net Income89.4108.921.55.4227.6158.8160.0255.9341.9182.1155.6392.5
+ Net Income — Continuing Ops89.4108.920.36.3227.5158.7160.0256.4341.9182.1155.6392.6
+ Other Comprehensive Income1.1-1.1-2.11.5-2.2-0.1-2.70.5-0.7-0.85.50.6
Total Comprehensive Income90.5107.919.46.9225.4158.6157.3256.3341.3181.3161.1393.2
Net Income to Common89.40.00.05.4227.60.0255.90.00.00.00.0
Minority Interest0.00.00.00.0-2.20.00.00.00.00.00.0
Per Share
Basic EPS1.101.330.260.072.791.951.963.143.301.751.503.78
Diluted EPS1.101.330.260.072.791.941.963.133.291.751.503.78
Other Comprehensive Income — detail
+ Other Comprehensive Income-2.70.5-0.7-0.85.50.6
+ Items NOT to be Reclassified to P&L1.4-1.5-1.20.7-2.8-0.2-3.7-0.1-1.0-1.17.10.8
+ Tax on Items NOT to be Reclassified-0.9-0.0-0.3-0.31.80.2
+ Tax on Items NOT to be Reclassified — alt tag0.4-0.4-0.30.2-0.7-0.1
+ Items to be Reclassified to P&L0.00.1-1.21.0-0.20.0-0.00.50.10.00.20.1
Comprehensive Income — Owners of Parent1.10.00.01.50.00.00.00.50.00.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations1.101.330.260.072.791.951.963.143.301.751.503.78
Diluted EPS — Continuing Operations1.101.330.260.072.791.941.963.133.291.751.503.78
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit776.5724.1593.1655.51,018.4931.0982.31,061.31,610.91,339.71,318.91,653.4
Gross Margin %21.0827.9026.4527.5726.4922.6828.1128.2723.4423.3028.0527.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)120.4153.525.014.2295.8220.2223.0342.3468.5274.7200.3504.4
− Exceptional Items (reconciliation)0.00.00.00.00.00.00.00.00.0-41.31.921.8
Net Income Adj (tax-effected)89.4108.921.55.4227.6158.8160.0255.9341.9214.3154.2376.3
EPS Adj1.101.330.260.072.791.951.963.143.302.061.493.62
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Filed Debt Equity0.010.000.010.010.010.010.010.010.010.010.010.01
Filed Dscr0.000.000.010.000.010.010.020.010.020.020.020.01
Filed Iscr0.010.000.010.010.030.030.030.050.050.040.040.05
Paid Up Equity Capital814.7814.7814.8814.8814.8815.2815.2815.2816.41,038.01,038.21,038.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.